Evidence map›Paper›PMID 39720759›Full record

ArticleHealthcare technology letters2024

BREAST+: An augmented reality interface that speeds up perforator marking for DIEAP flap reconstruction surgery.

Rafaela Timóteo, David Pinto, Pedro Matono, Carlos Mavioso, Maria-João Cardoso, Pedro Gouveia, Tiago Marques, Daniel Simões Lopes

Abstract read
In one paragraph

Article in Healthcare technology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rafaela TimóteoBreast Unit Champalimaud Foundation Aven ida Brasília Lisboa Portugal.
David PintoBreast Unit Champalimaud Foundation Aven ida Brasília Lisboa Portugal.
Pedro MatonoITI/LARSyS Hub Criativo do Beato Factory Lisbon Lisboa Portugal.
Carlos MaviosoBreast Unit Champalimaud Foundation Aven ida Brasília Lisboa Portugal.
Maria-João CardosoBreast Unit Champalimaud Foundation Aven ida Brasília Lisboa Portugal.
Pedro GouveiaBreast Unit Champalimaud Foundation Aven ida Brasília Lisboa Portugal.
Tiago MarquesBreast Unit Champalimaud Foundation Aven ida Brasília Lisboa Portugal.
Daniel Simões LopesITI/LARSyS Hub Criativo do Beato Factory Lisbon Lisboa Portugal.ORCID https://orcid.org/0000-0003-0917-9396

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep inferior epigastric artery perforator flap reconstruction is a common technique for breast reconstruction surgery in cancer patients. Preoperative planning typically depends on radiological reports and 2D images to help surgeons locate abdominal perforator vessels before surgery. Here, BREAST+, an augmented reality interface for the HoloLens 2, designed to facilitate accurate marking of perforator locations on the patients' skin and to seamlessly access relevant clinical data in the operating room is proposed. The system is evaluated in a controlled setting by conducting a user study with 27 medical students and 2 breast surgeons. Quantitative (marking error, task completion time, and number of task repetitions) and qualitative (perceived usability, perceived workload, user preference and user satisfaction) data are collected to assess BREAST+ performance during perforator marking. The average time taken to mark each perforator is 7.7 ± 6.5 s, with an average absolute error of 6.8 ± 2.6 mm and an estimated average deviation of 3.6 ± 1.4 mm. The results revealed non-negligeable biases in user estimates likely attributed to depth perception inaccuracies. Still, the study concluded that BREAST+ is both accurate and considerably more efficient (∼6 times faster) when compared to the conventional perforator marking approach.

Indexed as

augmented realitysurgeryuser interfaces

Identifiers

PMID39720759
PMCPMC11665790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.